Health

N.Y. official rejects independent fracking study

New York Department of Environmental Conservation Commissioner Joe Martens has rejected requests by health and environmental groups to have an independent party assess the health impact of the natural gas extraction method called “hydraulic fracturing” or “fracking.”

Gov. Andrew Cuomo is awaiting the results of a DEC review begun in 2008 before deciding whether to allow high-volume fracking in New York.

Fracking involves pumping large quantities of water underground to break ...

continue reading...

Senate candidate on defensive over asbestos issue

Lawyer Elizabeth Warren, a Democratic U.S. Senate candidate from Massachusetts, is defending her representation of an insurance company in an asbestos lawsuit, the Boston Globe reports.

Warren’s Republican opponent, U.S. Senator Scott Brown, has attacked her for representing Travelers Insurance in a 2009 lawsuit. Brown alleges that Warren’s work on behalf of a corporate client undercuts her reputation as a consumer advocate.

Breathing high levels of asbestos fibers can lead to an ...

continue reading...

Former manager: J&J encouraged illegal tactics

A former Johnson & Johnson sales manager testified that the company promoted the illegal marketing of its antipsychotic drug Risperdal through tactics such as paying doctors to give favorable speeches and subsidizing golf trips, Bloomberg reports.

In 2003, company officials specifically urged salespeople to visit doctors who treat children, with the intention of getting more children on the drug – at a time when the drug wasn’t approved for children.

The former ...

continue reading...

Research may aid treatment of depression

According to a Reuters story, scientists have identified biological markers in the blood that may eventually help doctors match patients to the best type of treatment for depression.

The story says major depression affects around 20 percent of people at some point in their lives, and the World Health Organization predicts it will soon rival heart disease as the health disorder with the highest global disease burden.

But up to now, treatment ...

continue reading...

FDA sets deadline for blood thinner approval

According to Reuters, the U.S. Food and Drug Administration has set March 17 as the deadline for deciding whether to approve blood thinner Eliquis for patients with atrial fibrillation.

The agency declined to approve the drug in June, requesting that manufacturers Bristol-Myers Squibb Co and Pfizer Inc. provide more information on a pivotal clinical trial of the medicine, which is designed to reduce the risk of stroke caused by blood ...

continue reading...

Study says going off blood thinner is dangerous

New research indicates that people who stop taking the blood thinner warfarin over concerns about gastrointestinal bleeding raise their risk of blood clots and death if they remain off the drug, according to U.S. News and World Report.

Warfarin makes it harder for clots to form and block the blood stream, and is prescribed to ward off conditions such as stroke that are caused by blood clots. It also raises ...

continue reading...
Page 70 of 120 «...4050606869707172...»